amfAR, The Foundation for AIDS Research

Hepatitis C

In the United States, an estimated 50-90 percent of injection drug users living with HIV are co-infected with HCV. Driven by rising rates of injection drug use, the incidence of hepatitis C in the United States has tripled in the last five years. The amfAR policy office advocates for increased access to prevention and treatment services for people living with, or at risk for, hepatitis C. policy office maintains a database of epidemiological, policy, and funding data on opioid use, HIV, and hepatitis C.